Skip to main content
. 2021 May 4;8(11):ofab223. doi: 10.1093/ofid/ofab223

Table 1.

Characteristics of the 104 Patients

Characteristic Febrile Neutropenia
(n = 97)
Neutropenia Without Fever (n = 7)
Age, y, median 7 6
Age distribution, No. (%)
 ≤2 y 17 (17.5) 1 (16.7)
 3–5 y 24 (24.7) 2 (33.3)
 6–10 y 22 (22.7) 3 (50.0)
 11–15 y 27 (27.8) 1 (16.7)
 ≥16 y 7 (7.2) 0 (0)
Sex, male, No. (%) 67 (69.0) 4 (57.1)
Cause of neutropenia, No. (%)
 Cancer chemotherapy 80 (82.5) 5 (71.4)
 HSCT 12 (12.4) 1 (14.3)
 Underlying disease 5 (5.2) 1 (14.3)
Primary medical condition, No. (%)
 Leukemia 43 (44.3) 3 (50.0)
 Solid tumors 34 (35.1) 2 (33.3)
 Bone marrow failure 9 (9.3) 1 (16.7)
 Lymphoma 5 (5.2) 0 (0)
 CNS tumors 4 (4.1) 1 (16.7)
 Primary immunodeficiency 2 (2.1) 0 (0)
Clinical symptoms, No. (%)
 Oral 16 (16.5) 1 (14.3)
 Skin 5 (5.2) 0 (0)
 Gastrointestinal 20 (20.6) 0 (0)
 Other(s) 5 (5.2) 0 (0)
Blood culture test positive, No. (%) 10 (10.3)

Fifteen FN patients and three NE patients were excluded due to low quality of their samples for sequencing.

Abbreviations: CNS, central nervous system; HSCT, hematopoietic stem cell transplantation.